By Michael D. O’Donnell
The patient was a 60 year old female with a history heavy chain (AH) amyloidosis with renal and cardiac involvement, nephrotic syndrome, and hyperlipidemia who presented with …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
From The Archives: Should My Patient with a Solid Tumor be Anticoagulated in the Absence of Venous Thromboembolism?
March 6, 2014
Please enjoy this post from the archives dated September 8, 2011
By David Altszuler, Class of 2012
Faculty Peer Reviewed
An empiric association between occult malignancy and thrombophlebitis has been recognized since Trousseau first reported the syndrome in 1865.[1] The mechanism …
West Nile Virus: Just How Bad Is It?
March 5, 2014
By Julian Horwitz
Peer Reviewed
As of mid-August 2012, the CDC had reported 1118 cases of West Nile virus (WNV) infections and 41 related deaths, which, pro rata, made 2012 the most …
Primecuts – This Week In The Journals
March 3, 2014
By Kerrilynn Carney, MD
Peer reviewed
This week in global, national, and local news: the Winter Olympics came to a close in Sochi with Russia leading the medal count; Arizona Governor Jan …
School Fees Or Head CTs: Reflections For Ethical Clinical Practice
February 28, 2014
By Steffen Haider, MD
Peer Reviewed
She was a thin, 4-year old girl brought to the Accident Centre by her mother for evaluation of new-onset bruising around the eyes after …
The Yolk Or The Egg
February 27, 2014
By Nicole A. Lamparello, MD and Molly Somberg, MD, MPA
Peer Reviewed
You hear it wherever you eat, whether at the deli ordering a breakfast sandwich or at the diner for Sunday …
Primecuts – This Week In The Journals
February 24, 2014
By Miguel A. Saldivar, MD
Peer Reviewed
This week’s edition of Primecuts brings highlights from studies on a variety of topics ranging from prescription drug abuse to cost-effective medical care. Given that …
An antidote on the horizon? An update on the progress toward achieving reversibility for the new oral anticoagulants
February 21, 2014
By Gabriel Schneider, MD
Peer Reviewed
The new oral anticoagulants (NOACs) are an appealing alternative to the burdensome vitamin K antagonists such as warfarin. These novel agents include direct thrombin inhibitors such …